Research keywords (3)：
Proteolysis targeting chimera: PROTAC
, CTC (Circulating tumor cell)
, PSMA(Prostate Specific Membrane Antigen)
Research theme for competitive and other funds (3)：
2022 - 2025 The impact of PSMA-targeted proteolysis induction on advanced prostate cancer
2019 - 2022 Search for biomarkers on immunotherapy for metastatic renal cancer by using circulating tumor cells and repertoire analysis
前立腺がんにおける転移予測バイオマーカー開発
Papers (19)：
So Nakamura, Masayoshi Nagata, Naoya Nagaya, Takeshi Ashizawa, Hisashi Hirano, Yan Lu, Hisamitsu Ide, Shigeo Horie. The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide. Cancers. 2024. 16. 4
Takuro Kobayashi, Masayoshi Nagata, Yoshihiro Ikehata, Yuki Nagashima, Naoya Nagaya, Yan Lu, Shigeo Horie. T-Cell Receptor Repertoire as a Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma. Current issues in molecular biology. 2023. 45. 11. 8939-8949
Naoya Nagaya, Kevin J Chua, Joshua Sterling, Shigeo Horie, Isaac Y Kim. Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates. Prostate international. 2023. 11. 2. 107-112
Hisashi Hirano, Masayoshi Nagata, Naoya Nagaya, So Nakamura, Takeshi Ashizawa, Yan Lu, Haruna Kawano, Kosuke Kitamura, Yoshiro Sakamoto, Kazuhiko Fujita, et al. Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases. Scientific reports. 2023. 13. 1. 8704-8704
Yoshihiro Ikehata, Yuki Nakagawa, Katsuhito Yuzawa, Tomoya Shirakawa, Azusa Yoshiyama, So Nakamura, Yuki Nagashima, Keisuke Ishikawa, Naoya Nagaya, Takeshi Ashizawa, et al. Kidney Transplantation for a Patient With Protein C Deficiency Using Activated Protein C Concentrate: A Case Report. Transplantation proceedings. 2022. 54. 10. 2754-2757
2014 - 2018 Juntendo University Graduate School of Medicine
2006 - 2012 Juntendo University Faculty of Medicine
Professional career (1)：
PhD (Juntendo University Graduate School of Medicine)
Work history (5)：
2022/04 - 現在 Juntendo University Shizuoka Hospital Urology Associate Professor
2021/04 - 2022/03 Juntendo University Graduate School of Medicine Urology Assistant Professor
2018/11 - 2021/03 Rutgers Cancer Institute of New Jersey Urology
2014/04 - 2018/03 Juntendo University Urology Resident
2012/04 - 2014/03 順天堂大学附属静岡病院 臨床研修センター 初期臨床研修医
Awards (1)：
European Society for Medical Oncology (ESMO) Best Poster, in the category of Genitourinary tumours, prostate, at ESMO Asia Congress 2023. Prognosis of metastatic castration resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells
Association Membership(s) (5)：
Japanese Society of Medical Oncology
, The Japanese Urological Association
, The Japanese Cancer Association
, Japanese Society of Endourology and Robotics
, The Japanese Association for Molecular Target Therapy of Cancer
